Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Total Debt (2019 - 2025)

Historic Total Debt for Biodesix (BDSX) over the last 7 years, with Q3 2025 value amounting to $47.1 million.

  • Biodesix's Total Debt rose 3045.8% to $47.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $47.1 million, marking a year-over-year increase of 3045.8%. This contributed to the annual value of $36.4 million for FY2024, which is 3621.81% down from last year.
  • As of Q3 2025, Biodesix's Total Debt stood at $47.1 million, which was up 3045.8% from $46.8 million recorded in Q2 2025.
  • Biodesix's 5-year Total Debt high stood at $57.1 million for Q4 2023, and its period low was $14.2 million during Q3 2022.
  • Over the past 5 years, Biodesix's median Total Debt value was $36.8 million (recorded in 2023), while the average stood at $37.4 million.
  • Its Total Debt has fluctuated over the past 5 years, first tumbled by 6713.45% in 2022, then skyrocketed by 21241.71% in 2023.
  • Over the past 5 years, Biodesix's Total Debt (Quarter) stood at $27.8 million in 2021, then increased by 27.34% to $35.3 million in 2022, then surged by 61.5% to $57.1 million in 2023, then crashed by 36.22% to $36.4 million in 2024, then rose by 29.4% to $47.1 million in 2025.
  • Its last three reported values are $47.1 million in Q3 2025, $46.8 million for Q2 2025, and $36.7 million during Q1 2025.